Patent details

91403 Product Name: Formulation couverte par les revendications 1,2,5,6,7,8,9,11et 13 comprenant tout ester et sels pharmaceutiquement acceptables des composés individuels Nom du produit : Aerinaze (Desloratadine/Pseudoephedrine)

Basic Information

Publication number:
91403
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP003114436
Legal Status:
Expired
Application number:
91403
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/07/399/001-006 - Aerinaze
Marketing Authorization Type:
Marketing Authorization Date:
30/07/2007
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
21/12/2007
First Marketing Authorization date:
30/07/2007
Grant date:
21/02/2008
Activation date:
20/12/2020
Publication date:
21/02/2008
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
30/07/2022
SPC Extension Expiration:
30/07/2022
Rejection date:
Withdrawal date:

Owner

From:
09/07/2012
 
 

Name:
MERCK SHARP & DOHME CORP.
Address:
EAST LINCOLN AVENUE 126, RAHWAY, NEW JERSEY 07065, United States (US)

History of Owners

From:
21/12/2007
To:
08/07/2012

Name:
SCHERING CORPORATION
Address:
2000 Galloping Hill Road, Kenilworth, New Jersey 07033-0530, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
21/12/2007
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
Cho Wing-Kee Philip
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2021/01
Publication date:
05/01/2021
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/09/2021
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages